Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient

Clinical trial NCT06587542 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06587542
Sponsor: Universitas Padjadjaran
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Anogenital Warts HIV Infection Tuberculin Purified Protein Derivative

Start date: 2024-09-15
Primary completion: 2025-09-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.